This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
HDMA President and CEO John M. Gray released a statement in support of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015, introduced by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.) The legislation is a companion to House legislation (H.R. 471) sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)
“A strong, collaborative relationship between the nation’s pharmaceutical supply chain and enforcement agencies ― such as the Drug Enforcement Administration ― is critical to the ability of our country to help mitigate prescription drug abuse and diversion. The bipartisan legislation introduced by Senators Hatch and Whitehouse is an important step forward in achieving this goal, by promoting transparency in the fight against abuse and diversion. It is HDMA’s hope and expectation that this Senate bill will have the same broad support and momentum that the House legislation currently enjoys.”
>> For more information, click here
